Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgia Mori

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|February 2, 2021
Gut Microbial Signatures in Sporadic and Hereditary Colorectal CancerGiorgia Mori, Maria Rosalia Pasca
Plos Pathogens|April 15, 2021
Microbiome-immune interactions in tuberculosisGiorgia Mori, Mark Morrison, Antje Blumenthal
Drug Discovery Today|September 22, 2016
New prodrugs against tuberculosisGiorgia Mori, Laurent Roberto Chiarelli, Giovanna Riccardi, et al.
Current Medicinal Chemistry|September 27, 2016
New and Old Hot Drug Targets in TuberculosisLaurent Roberto Chiarelli, Giorgia Mori, Marta Esposito, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal ChemistryElisa Azzali, Miriam Girardini, Giannamaria Annunziato, et al.
Microbiology Spectrum|June 8, 2023
Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosisRachel F Rollo, Giorgia Mori, Timothy A Hill, et al.
European Journal of Medicinal Chemistry|November 26, 2013
Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosisTetiana Matviiuk, Giorgia Mori, Christian Lherbet, et al.
Frontiers in Microbiology|March 12, 2020
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular ProdrugGiorgia Mori, Beatrice Silvia Orena, Laurent R Chiarelli, et al.
Chemmedchem|April 22, 2016
Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular ActivityDamien Veau, Serhii Krykun, Giorgia Mori, et al.
Immunology|November 12, 2022
Distinct contributions of the innate immune receptors TLR2 and RP105 to formation and architecture of structured lung granulomas in mice infected with Mycobacterium tuberculosisMeg L Donovan, Helle Bielefeldt-Ohmann, Rachel F Rollo, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|February 2, 2021
Gut Microbial Signatures in Sporadic and Hereditary Colorectal CancerGiorgia Mori, Maria Rosalia Pasca
Plos Pathogens|April 15, 2021
Microbiome-immune interactions in tuberculosisGiorgia Mori, Mark Morrison, Antje Blumenthal
Drug Discovery Today|September 22, 2016
New prodrugs against tuberculosisGiorgia Mori, Laurent Roberto Chiarelli, Giovanna Riccardi, et al.
Current Medicinal Chemistry|September 27, 2016
New and Old Hot Drug Targets in TuberculosisLaurent Roberto Chiarelli, Giorgia Mori, Marta Esposito, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal ChemistryElisa Azzali, Miriam Girardini, Giannamaria Annunziato, et al.
Microbiology Spectrum|June 8, 2023
Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosisRachel F Rollo, Giorgia Mori, Timothy A Hill, et al.
European Journal of Medicinal Chemistry|November 26, 2013
Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosisTetiana Matviiuk, Giorgia Mori, Christian Lherbet, et al.
Frontiers in Microbiology|March 12, 2020
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular ProdrugGiorgia Mori, Beatrice Silvia Orena, Laurent R Chiarelli, et al.
Chemmedchem|April 22, 2016
Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular ActivityDamien Veau, Serhii Krykun, Giorgia Mori, et al.
Immunology|November 12, 2022
Distinct contributions of the innate immune receptors TLR2 and RP105 to formation and architecture of structured lung granulomas in mice infected with Mycobacterium tuberculosisMeg L Donovan, Helle Bielefeldt-Ohmann, Rachel F Rollo, et al.
Pageof 3